Harvard’s serial entrepreneur Timothy Springer has formally launched his latest venture with a $101m series A round backed by GV.

Seismic Therapeutic, a US-based immunotherapy discovery technology developer, formally launched on Wednesday with $101m in series A funding from investors including co-founder Timothy Springer, a professor at Harvard University’s Medical School. Venture capital firm Lightspeed Venture Partners led the round, which also featured internet technology group Alphabet’s GV unit, Boxer Capital, Polaris Partners, Samsara BioCapital…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.